Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma [NA]
A completed clinical trial comparing cytoreductive surgery plus transarterial chemoembolization (TACE) versus TACE alone for hepatocellular …
-
CLINICAL_TRIALS trial_result · 2013-07-23Clinical Trial Update: Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication [Phase 4]
Phase 4 clinical trial update evaluating chemoembolization with or without antiviral therapy for unresectable HBV-related hepatocellular car…
-
CLINICAL_TRIALS trial_result · 2013-07-22Clinical Trial Update: Study of Hepatocellular Carcinoma in Cirrhotic Patients
This document reports the completion of a clinical trial evaluating hepatocellular carcinoma in patients with cirrhosis.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Epirubicin and Thalidomide in Treating Patients With Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating epirubicin in combination with thalidomide for liver cancer has completed.
-
CLINICAL_TRIALS research · 2013-07-11Clinical Trial Update: VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway
The document discusses VEGF signaling promoting cell growth and metastasis in hepatocellular carcinoma via a VEGF receptor–mediated pathway.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer [Phase 2]
Phase 2 clinical trial update shows completion and results posting for bevacizumab plus erlotinib in adults with hepatocellular carcinoma. T…
-
CLINICAL_TRIALS withdrawal · 2013-07-04Clinical Trial Update: Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer [Phase 2]
A Phase 2 trial evaluating pegylated liposomal doxorubicin and temsirolimus for advanced hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial of veliparib with cisplatin and gemcitabine in advanced biliary tract, pancreatic, urothelial, and non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Tamoxifen in Treating Patients With Primary Liver Cancer [Phase 3]
A Phase 3 clinical trial evaluating tamoxifen for primary liver cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer [Phase 2]
A completed Phase 2 trial evaluating the combination of irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma (live…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Oxaliplatin in Treating Patients With Liver Cancer [Phase 2]
A Phase 2 clinical trial evaluating oxaliplatin for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [Phase 1]
This Phase 1 trial evaluated the safety and preliminary efficacy of combining sirolimus with bevacizumab in patients with unresectable liver…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Phase 2]
Phase 2 trial update evaluating Cediranib in adults with locally advanced or metastatic hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2013-06-05Clinical Trial Update: Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma [Phase 2, Phase 3]
This entry describes an ongoing Phase 2/Phase 3 clinical trial evaluating arsenic trioxide delivered via transarterial chemoembolization (TA…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) [Phase 2]
A completed Phase 2 clinical trial funded by the National Cancer Institute evaluated the proteasome inhibitor bortezomib for hepatocellular …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer [Phase 2]
Phase 2 study evaluating Erlotinib in adults with unresectable hepatocellular carcinoma, cholangiocarcinoma, or gallbladder cancer has compl…
-
CLINICAL_TRIALS research · 2013-06-04Clinical Trial Update: Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and Biomarkers [NA]
This clinical trial update describes noninvasive imaging and biomarkers to monitor response to concurrent chemoradiotherapy in advanced hepa…
-
CLINICAL_TRIALS withdrawal · 2013-05-30Clinical Trial Update: Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer [Phase 3]
A Phase 3 trial evaluating surgery with or without hepatic arterial chemotherapy for liver cancer in adults and children has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of Regorafenib [Phase 1]
This Phase 1 study assessed how a high-fat versus low-fat breakfast affects regorafenib pharmacokinetics; the trial has completed.
-
CLINICAL_TRIALS research · 2013-05-23Clinical Trial Update: Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient [Phase 2]
Phase 2 clinical trial comparing combined transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) versus RFA monotherapy fo…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery [Phase 2]
A Phase 2 trial evaluated the combination of bevacizumab and erlotinib for unresectable hepatocellular carcinoma to assess efficacy and safe…
-
CLINICAL_TRIALS research · 2013-04-30Clinical Trial Update: Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma [NA]
This clinical trial update describes research on whether genetic polymorphisms in heat shock protein 70 are associated with hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer [NA]
This clinical trial evaluated PET imaging with carbon-11 acetate and fluorodeoxyglucose F-18 for detecting hepatocellular carcinoma in patie…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Tumor Growth Factors in Hepatocellular Carcinoma
This completed clinical trial investigated tumor growth factors in hepatocellular carcinoma. The study was sponsored by Kaohsiung Medical Un…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma [NA]
This clinical trial update describes associations of interleukin-1B and TNF-α gene polymorphisms with HBV-related hepatocellular carcinoma a…